Syncope, a transient loss of consciousness due to global cerebral hypoperfusion, presents a diagnostic challenge due to its multifactorial etiology. This article aims to provide a comprehensive approach to diagnosing and managing syncope in clinical practice.
It is crucial to classify syncope into reflex, orthostatic hypotension, and cardiac syncope. Reflex syncope, the most common, includes vasovagal, situational, and carotid sinus syncope. Orthostatic hypotension could be due to autonomic failure, volume depletion or drug-induced. Cardiac syncope, the most life-threatening, can be due to arrhythmias or structural heart diseases.
A structured approach to diagnosis involves a detailed history, physical examination, and targeted investigations. The history should focus on identifying prodromal symptoms, triggers, and family history of sudden cardiac death. The physical examination should include orthostatic blood pressure measurements and cardiovascular examination. Electrocardiogram (ECG) is the most important initial investigation. Further investigations like echocardiography, tilt table testing, Holter monitoring, or electrophysiological studies may be required based on initial findings.
Management should be directed towards the underlying cause. Reflex syncope can often be managed with lifestyle modifications and patient education. Orthostatic hypotension requires volume replacement, discontinuation of offending drugs, and sometimes pharmacotherapy. Cardiac syncope may require antiarrhythmic drugs, pacemakers, or even defibrillators.
Despite the diagnostic challenge, a systematic approach can aid in identifying the underlying cause of syncope. Timely diagnosis and appropriate management can significantly reduce morbidity and mortality associated with this condition. Continued research is needed to further our understanding of this complex clinical entity and to develop more effective diagnostic and therapeutic strategies.
1.
Combo Therapy Boosts Early CML Response but Not Long Term
2.
PNH With Extravascular Hemolysis Approves Factor D Inhibitor.
3.
In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.
4.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
5.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
1.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
2.
Decoding Hamartomas: Understanding Their Causes and Symptoms
3.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
Efficient Management of First line ALK-rearranged NSCLC
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation